ASY timeline
Every ASY batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| ASY-{CAT}-2288 | Retatrutide | 26 Aug 2026 | 2026-Q3 | 11 | 98.45 | 1.90 | 98.65 | +0.20 | |
| ASY-{CAT}-2167 | TB-500 | 13 Jun 2026 | 2026-Q3 | 9 | 99.93 | 0.15 | 99.90 | -0.03 | |
| ASY-{CAT}-2969 | Selank | 12 May 2026 | 2026-Q2 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| ASY-{CAT}-1521 | ARA-290 | 30 Apr 2026 | 2026-Q3 | 1 | 99.66 | n<2 | 99.65 | -0.01 | |
| ASY-{CAT}-2426 | GHRP-2 | 12 Apr 2026 | 2026-Q2 | 6 | 99.80 | 0.69 | 99.76 | -0.04 | |
| ASY-{CAT}-2139 | SS-31 (Elamipretide) | 18 Feb 2026 | 2026-Q2 | 4 | 99.87 | 0.17 | 99.86 | -0.01 | |
| ASY-{CAT}-1840 | MOTS-c | 06 Feb 2026 | 2026-Q2 | 1 | 99.40 | n<2 | 99.31 | -0.09 | |
| ASY-{CAT}-2827 | Exenatide | 03 Feb 2026 | 2026-Q2 | 12 | 99.33 | 0.63 | 99.02 | -0.31 | |
| ASY-{CAT}-2315 | GHRP-6 | 03 Jan 2026 | 2026-Q1 | 1 | 98.78 | n<2 | 99.13 | +0.35 | |
| ASY-{CAT}-2379 | PEG-MGF | 04 Nov 2025 | 2026-Q2 | 2 | 98.70 | 0.26 | 98.78 | +0.08 | |
| ASY-{CAT}-1505 | Retatrutide | 03 Nov 2025 | 2026-Q2 | 3 | 98.09 | 1.27 | 98.63 | +0.54 | |
| ASY-{CAT}-2719 | BPC-157 | 07 Oct 2025 | 2025-Q4 | 2 | 99.70 | 0.19 | 99.61 | -0.09 | |
| ASY-{CAT}-2158 | KPV | 07 Sep 2025 | 2025-Q4 | 1 | 99.83 | n<2 | 99.90 | +0.07 | |
| ASY-{CAT}-2288 | Pramlintide | 20 Aug 2025 | 2025-Q4 | 11 | 98.95 | 0.96 | 99.16 | +0.21 | |
| ASY-{CAT}-2128 | BPC-157 | 12 Aug 2025 | 2025-Q4 | 5 | 99.87 | 0.35 | 99.90 | +0.03 | |
| ASY-{CAT}-1806 | Enclomiphene citrate | 09 Jul 2025 | 2025-Q4 | 9 | 99.88 | 0.37 | 99.58 | -0.30 | |
| ASY-{CAT}-1276 | BPC-157 | 13 Jun 2025 | 2025-Q3 | 5 | 99.59 | 0.68 | 99.88 | +0.29 | |
| ASY-{CAT}-2101 | Liraglutide | 07 Jun 2025 | 2025-Q4 | 8 | 99.90 | 0.34 | 99.84 | -0.06 | |
| ASY-{CAT}-1898 | Oxytocin | 23 May 2025 | 2025-Q4 | 13 | 99.93 | 0.65 | 99.61 | -0.32 | |
| ASY-{CAT}-2031 | Thymosin α1 | 24 Apr 2025 | 2025-Q2 | 7 | 99.37 | 0.61 | 99.90 | +0.53 | |
| ASY-{CAT}-1298 | Selank | 17 Mar 2025 | 2025-Q2 | 2 | 99.63 | 0.40 | 99.90 | +0.27 | |
| ASY-{CAT}-1860 | Retatrutide | 07 Mar 2025 | 2025-Q3 | 8 | 98.01 | 1.21 | 98.19 | +0.18 | |
| ASY-{CAT}-1938 | Tirzepatide | 06 Mar 2025 | 2025-Q3 | 4 | 99.03 | 0.72 | 99.02 | -0.01 | |
| ASY-{CAT}-1626 | Vilon | 17 Feb 2025 | 2025-Q3 | 8 | 99.93 | 0.28 | 99.78 | -0.15 | |
| ASY-{CAT}-2221 | Humanin (HNG) | 06 Feb 2025 | 2025-Q3 | 2 | 98.97 | 0.68 | 99.39 | +0.42 | |
| ASY-{CAT}-2147 | N-Acetyl Semax Amide | 03 Jan 2025 | 2025-Q1 | 5 | 99.88 | 0.61 | 99.90 | +0.02 | |
| ASY-{CAT}-2342 | Retatrutide | 02 Jan 2025 | 2025-Q2 | 4 | 99.35 | 1.49 | 99.45 | +0.10 | |
| ASY-{CAT}-1787 | Tirzepatide | 18 Dec 2024 | 2025-Q2 | 1 | 98.44 | n<2 | 98.30 | -0.14 | |
| ASY-{CAT}-1489 | Tirzepatide | 10 Dec 2024 | 2025-Q1 | 5 | 98.78 | 0.54 | 98.77 | -0.01 | |
| ASY-{CAT}-1786 | Hexarelin | 12 Nov 2024 | 2025-Q1 | 11 | 99.82 | 0.54 | 99.90 | +0.08 | |
| ASY-{CAT}-1986 | Triptorelin | 03 Sep 2024 | 2024-Q4 | 1 | 99.93 | n<2 | 99.58 | -0.35 | |
| ASY-{CAT}-1244 | Tirzepatide | 28 Aug 2024 | 2025-Q1 | 7 | 98.47 | 0.58 | 98.39 | -0.08 | |
| ASY-{CAT}-2919 | Kisspeptin-10 | 04 May 2024 | 2024-Q4 | 11 | 99.66 | 0.83 | 99.88 | +0.22 | |
| ASY-{CAT}-2723 | PT-141 (Bremelanotide) | 17 Mar 2024 | 2024-Q3 | 9 | 99.57 | 0.76 | 99.79 | +0.22 |